• File Size 1.75 MB
• File Count 1
• Create Date January 28, 2025
• Last Updated January 28, 2025

Q4 2024 WuxiAppTec Evaluation

WuXi AppTec is a leading global contract research, development, and manufacturing organization (CRDMO) that provides a comprehensive suite of services to support the pharmaceutical, biotechnology, and medical device industries. The company offers services across the drug discovery, development, and manufacturing value chains, supporting the creation of small and large molecules, cell and gene therapies, and medical devices. WuXi AppTec's integrated platform combines its vast expertise in chemistry, biology, drug discovery, preclinical development, and clinical manufacturing to accelerate the development of new drugs and therapies. WuXi's services cater to a diverse range of clients, from startups to global pharmaceutical companies, making it a critical player in the biotechnology and pharmaceutical supply chain.